glp-1 drugs pharmaceutical companies news 2025 health pharma today obesity october Outlook for obesity in 2025: more FDA takes aim at telehealth

Legal overhangs To view or add a comment, sign in NutraIngredients quoted Claudia Lewis in "Supplement weight management claims in the GLP-1 era" on ongoing litigation regarding supplements advertised for weight loss

The diabetes drug liraglutide prevents degenerative processes in a mouse model of Alzheimer's disease

Isaacs says that while most people can safely take a GLP-1, you should avoid it if you have severe gastroparesis (stomach paralysis)

Thus, GLP-1R G-protein-biased ligands may offer new and unappreciated advantages in the context of chronic treatment such as promoting adipocyte hyperplasia, restoring insulin responsiveness and long-term glycaemic control while preserving pancreatic -cell function by minimizing the insulin secretory burden

GLP-1 analogues have completely changed this bleak therapeutic picture

This requires clarification directly with the company